倪貴榮教授個人網頁

TRIPs and Public Health

Agreements
• Doha Declaration on TRIPs and Public Health (PDF)
• Amendment of TRIPs (DOC)

WTO Documents
• Communication from the European Communities and Their Member States (IP/C/W/280) (DOC)
• Concept Paper Relating to Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health: Communication from the European Communities and Their Member States (IP/C/W/339) (DOC)
• Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health: Communication from the United States (IP/C/W/340) (DOC)
• Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Permanent Mission of Brazil on Behalf of the Delegations of Bolivia, Brazil, Cuba, China, Dominican Republic, Ecuador, India, Indonesia, Pakistan, Peru, Sri Lanka, Thailand and Venezuela) (IP/C/W/355) (DOC)
• Moratorium to Address Needs of Developing and Least-Developed Members with No or Insufficient Manufacturing Capacities in the Pharmaceutical Sector (IP/C/W/396) (DOC)
• Minutes of Meeting, 5 February 2003 (IP/C/M/38) (DOC)
• Paragraph 6 of the Doha Declaration on The TRIPS Agreement and Public Health: Communication form the ACP Group (IP/C/W/401) (DOC)
• Paragraph 6 of the Doha Declaration on The TRIPS Agreement And Public Health: Note from the Chairman (JOB(03)/177) (PDF)
• Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health, Draft Decision (IP/C/W/405) (DOC)
• Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health, Decision of 30 August 2003 (WT/L/540) (DOC)
• Minutes of Meeting, 7 November 2003 (IP/C/M/41)
• Minutes of Meeting, 13 November 2003 (The General Council Chairperson’s statement) (WT/GC/M/82) (DOC)
• Report on the Workshop on the WTO Decision on Access to Medicines at Affordable Prices for Countries with No or Insufficient Manufacturing Capacities, Organized by the Commonwealth Secretariat in Co-Operation with the ACP Geneva Office and the Agency for International Trade Information and Cooperation (AITIC) (IP/C/W/439) (DOC)
• Legal Arguments to Support the African Group Proposal on the Implementation of Paragraph 11 of the 30 August 2003 Decision (IP/C/W/440) (DOC)
• Implementation of Paragraph 11 of the 30 August 2003 Decision: Communication from Nigeria on Behalf of the African Group (IP/C/W/437/ Rev.1) (DOC)
• The TRIPS Agreement and Public Health: Communication from Rwanda on Behalf of the African Group (IP/C/W/445) (DOC)
• Request for an Extension of the Transitional Period Under Article 66.1 of the TRIPS Agreement: Communication from the Delegation of Zambia on Behalf of the Least-Developed Country Members (IP/C/W/457)(DOC)
• Annual Review of the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIP Agreement and Public Health (IP/C/37)
• Implementation of Paragraph 11 of the General Council Decision of 30 August 2003 on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health: Proposal for a Decision on an Amendment to the TRIPS Agreement (IP/C/41)
• Annual Review of the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIP Agreement and Public Health (IP/C/42)

Cases - WTO
• Canada - Term of Patent Protection (DOC)
• Canada - Patent Protection of Pharmaceutical Products (DOC)

National legislation
• Canada (PDF)
• China - English (LINK)
• China - Chinese (PDF)
• European Union (PDF)
• India (PDF)
• Netherlands (LINK)
• Norway (DOC)
• Switzerland (PDF)

Other Documents
• ACP-EU Joint Parliamentary Assembly Resolution (PDF)

Websites
• CPTech